Trulieve Cannabis Corp.

TRLV · NYSE · Stock · Healthcare
$9.97
-1.38% today
Delayed price,

What Trulieve Cannabis does

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.

Key facts

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Market cap
$1.92B
P/E (ttm)
—
Forward P/E
17.9
Dividend yield
0.00%
Beta
1.80
Profit margin
-41.6%
Employees
5,000
Headquarters
Tallahassee, FL, United States
Exchange
NYSE

Performance

1 Month
-9.9%
3 Months
+13.4%
6 Months
+56.5%
1 Year
+29.8%
5 Years
-62.7%
$4.6252-week range$13.28
Biggest setback — last 12 months
-47.2%
8 Dec 2025 → 23 Mar 2026
Fell from $9.91 to $5.23 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+133.5%
23 Mar 2026 → 21 Sept 2026
Ran from $5.23 to $12.21 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$7.83 (-21.4%)$9.97$12.69 (+27.3%)
3 Months$6.57 (-34.1%)$9.97$15.14 (+51.8%)
6 Months$5.52 (-44.6%)$9.97$18.00 (+80.5%)
12 Months$4.33 (-56.6%)$9.97$22.98 (+130.5%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 83.5%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 136,811 shares at $8.76 — Rivers Kim A., Chairman and CEO · 2026-06-26
Sold 1,080,000 shares at $8.17 — Rivers Kim A., Chairman and CEO · 2026-06-25
Sold 482,196 shares at $9.35 — Rivers Kim A., Chairman and CEO · 2026-06-22
Acquired 1,038,750 shares — Rivers Kim A., Chairman and CEO · 2026-03-17
Acquired 58,594 shares — Pernell Jason, President · 2026-03-17
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.